GMED has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GMED has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-30), Globus Medical's current share price is $50.29. Globus Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $1.36. Globus Medical's Cyclically Adjusted Price-to-FCF for today is 36.98.
The historical rank and industry rank for Globus Medical's Cyclically Adjusted Price-to-FCF or its related term are showing as below:
During the past years, Globus Medical's highest Cyclically Adjusted Price-to-FCF was 77.49. The lowest was 32.96. And the median was 55.22.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.
Globus Medical's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.592. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $1.36 for the trailing ten years ended in Dec. 2023.
The historical data trend for Globus Medical's Cyclically Adjusted Price-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Cyclically Adjusted Price-to-FCF | Get a 7-Day Free Trial | 58.30 | 43.03 | 44.32 | 37.02 | 39.25 |
For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:
* The bar in red indicates where Globus Medical's Cyclically Adjusted Price-to-FCF falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.
Globus Medical's Cyclically Adjusted Price-to-FCF for today is calculated as
Cyclically Adjusted Price-to-FCF | = | Share Price | / | Cyclically Adjusted FCF per Share |
= | 50.29 | / | 1.36 | |
= | 36.98 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:
For example, Globus Medical's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:
Adj_FreeCashFlowPerShare | = | Free Cash Flow per Share | / | CPI of Dec. 2023 (Change) | * | Current CPI (Dec. 2023) |
= | 0.592 | / | 129.4194 | * | 129.4194 | |
= | 0.592 |
Current CPI (Dec. 2023) = 129.4194.
Globus Medical Quarterly Data
Free Cash Flow per Share | CPI | Adj_FreeCashFlowPerShare | |
201403 | 0.242 | 99.695 | 0.314 |
201406 | 0.066 | 100.560 | 0.085 |
201409 | 0.337 | 100.428 | 0.434 |
201412 | -0.075 | 99.070 | -0.098 |
201503 | 0.286 | 99.621 | 0.372 |
201506 | -0.049 | 100.684 | -0.063 |
201509 | 0.193 | 100.392 | 0.249 |
201512 | 0.332 | 99.792 | 0.431 |
201603 | 0.480 | 100.470 | 0.618 |
201606 | 0.130 | 101.688 | 0.165 |
201609 | 0.374 | 101.861 | 0.475 |
201612 | 0.126 | 101.863 | 0.160 |
201703 | 0.431 | 102.862 | 0.542 |
201706 | 0.127 | 103.349 | 0.159 |
201709 | 0.225 | 104.136 | 0.280 |
201712 | 0.318 | 104.011 | 0.396 |
201803 | 0.397 | 105.290 | 0.488 |
201806 | 0.182 | 106.317 | 0.222 |
201809 | 0.358 | 106.507 | 0.435 |
201812 | 0.267 | 105.998 | 0.326 |
201903 | 0.109 | 107.251 | 0.132 |
201906 | 0.077 | 108.070 | 0.092 |
201909 | 0.429 | 108.329 | 0.513 |
201912 | 0.374 | 108.420 | 0.446 |
202003 | 0.196 | 108.902 | 0.233 |
202006 | 0.134 | 108.767 | 0.159 |
202009 | 0.357 | 109.815 | 0.421 |
202012 | 0.652 | 109.897 | 0.768 |
202103 | 0.487 | 111.754 | 0.564 |
202106 | 0.491 | 114.631 | 0.554 |
202109 | 0.570 | 115.734 | 0.637 |
202112 | 0.568 | 117.630 | 0.625 |
202203 | 0.238 | 121.301 | 0.254 |
202206 | 0.128 | 125.017 | 0.133 |
202209 | 0.206 | 125.227 | 0.213 |
202212 | 0.447 | 125.222 | 0.462 |
202303 | 0.365 | 127.348 | 0.371 |
202306 | 0.169 | 128.729 | 0.170 |
202309 | 0.251 | 129.860 | 0.250 |
202312 | 0.592 | 129.419 | 0.592 |
Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.
Thank you for viewing the detailed overview of Globus Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Leslie V Norwalk | director | C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130 |
Dan Wolterman | director | 3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130 |
John A Deford | director | C R BARD INC, 730 CENTRAL AVENUE, MURRAY HILL NJ 07974 |
Dan Lemaitre | director | 2 MUSICK, IRVINE CA 92618 |
Keith W Pfeil | officer: SVP, Chief Financial Officer | GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
Kelly Huller | officer: SVP, General Counsel | 2560 GENERAL ARMISTEAD AVENUE, AUDOBON PA 19403 |
David D Davidar | director, officer: Vice President, Operations | C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
James R Tobin | director | C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421 |
Daniel T Scavilla | officer: Senior VP and CFO | C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
David M Demski | director, officer: President and COO | C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
Robert Andrew Douglas | director | 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106 |
Stephen T Zarrilli | director | FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422 |
Anthony L Williams | officer: Senior VP of Bus. Devel. & GC | C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
Steven Payne | officer: Chief Accounting Officer | C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
David C Paul | director, 10 percent owner, officer: Chief Executive Officer | C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-07-2022
By GuruFocusNews GuruFocusNews • 06-17-2022
By PurpleRose PurpleRose • 07-18-2022
By sperokesalga sperokesalga • 05-15-2023
By Value_Insider Value_Insider • 10-19-2022
By GuruFocusNews GuruFocusNews • 05-28-2022
By GuruFocus Research GuruFocus Editor • 11-15-2022
By Marketwired • 10-24-2023
By sperokesalga sperokesalga • 02-12-2023
By GlobeNewswire GlobeNewswire • 04-19-2023